Pharmaceutical company Eli Lilly is pushing for FDA approval for Tirzepatide, a medication used to help control blood sugar for type-2 diabetics, to be used for another purpose: weight loss.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Breakingviews - Eli Lilly races rising obesity expectationsThe race is on between Mounjaro’s growth and investors’ burgeoning hopes. The drug made by Eli Lilly , which was approved in May to treat diabetes, reaped an astonishing $569 million of revenue in the first quarter less than a year after it was approved for sale. The results encouraged Lilly to raise its annual profit guidance by 3.5%. Investors are counting on that growth becoming exponential.
Read more »
Powerful new obesity drug from Eli Lilly and Co. poised to upend weight loss careAs a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment.
Read more »
People with diabetes lost up to 34 pounds taking Eli Lilly drug, company saysThe results add to evidence that the drug, tirzepatide, can be used as an effective weight loss aid.
Read more »
Even stronger obesity drug could further upend weight-loss careAs a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment.
Read more »
New weight loss drug on fast-track to rival Ozempic, WegovyDrugmaker Eli Lilly said it's seeking FDA approval of its drug Mounjaro to treat weight loss after late-stage trials showed unprecedented results.
Read more »
Philly mayoral candidate Helen Gym under scrutiny for 2019 pharmaceutical bill voteTV ads are attacking Philadelphia mayoral candidate Helen Gym over her 2019 vote in City Council on a pharmaceutical bill while her husband worked in the industry.
Read more »